tiprankstipranks
Vivos Inc Secures Leadership Continuity with CEO Contract Renewal
Company Announcements

Vivos Inc Secures Leadership Continuity with CEO Contract Renewal

Vivos Inc (RDGL) has issued an update.

Vivos, Inc. has renewed its Executive Employment Agreement with CEO Dr. Michael Korenko, effective January 1, 2024, for two more years. Korenko will earn a $295,500 annual salary, receive 20,000 shares of restricted stock, be eligible for up to $40,000 in annual bonuses based on performance, and get standard benefits and expense reimbursements. The agreement includes clauses for confidentiality, non-competition, and non-solicitation.

For a thorough assessment of RDGL stock, go to TipRanks’ Stock Analysis page.

Related Articles
GlobeNewswireVivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
GlobeNewswireRadiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!